BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 11994337)

  • 1. Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height.
    Quigley CA; Crowe BJ; Anglin DG; Chipman JJ
    J Clin Endocrinol Metab; 2002 May; 87(5):2033-41. PubMed ID: 11994337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normalization of height in girls with Turner syndrome after long-term growth hormone treatment: results of a randomized dose-response trial.
    Sas TC; de Muinck Keizer-Schrama SM; Stijnen T; Jansen M; Otten BJ; Hoorweg-Nijman JJ; Vulsma T; Massa GG; Rouwe CW; Reeser HM; Gerver WJ; Gosen JJ; Rongen-Westerlaken C; Drop SL
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4607-12. PubMed ID: 10599727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Final height of patients with Turner's syndrome treated with growth hormone (GH): indications for GH therapy alone at high doses and late estrogen therapy. Italian Study Group for Turner Syndrome.
    Cacciari E; Mazzanti L
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4510-5. PubMed ID: 10599710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome.
    Menke LA; Sas TC; de Muinck Keizer-Schrama SM; Zandwijken GR; de Ridder MA; Odink RJ; Jansen M; Delemarre-van de Waal HA; Stokvis-Brantsma WH; Waelkens JJ; Westerlaken C; Reeser HM; van Trotsenburg AS; Gevers EF; van Buuren S; Dejonckere PH; Hokken-Koelega AC; Otten BJ; Wit JM
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1151-60. PubMed ID: 20061421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Final height in girls with turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens.
    van Pareren YK; de Muinck Keizer-Schrama SM; Stijnen T; Sas TC; Jansen M; Otten BJ; Hoorweg-Nijman JJ; Vulsma T; Stokvis-Brantsma WH; Rouwé CW; Reeser HM; Gerver WJ; Gosen JJ; Rongen-Westerlaken C; Drop SL
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1119-25. PubMed ID: 12629094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone therapy of Turner syndrome: the impact of age of estrogen replacement on final height. Genentech, Inc., Collaborative Study Group.
    Chernausek SD; Attie KM; Cara JF; Rosenfeld RG; Frane J
    J Clin Endocrinol Metab; 2000 Jul; 85(7):2439-45. PubMed ID: 10902791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone plus childhood low-dose estrogen in Turner's syndrome.
    Ross JL; Quigley CA; Cao D; Feuillan P; Kowal K; Chipman JJ; Cutler GB
    N Engl J Med; 2011 Mar; 364(13):1230-42. PubMed ID: 21449786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth Hormone.
    van Teunenbroek A; de Muinck Keizer-Schrama SM; Stijnen T; Jansen M; Otten BJ; Delemarre-van de Waal HA; Vulsma T; Wit JM; Rouwé CW; Reeser HM; Gosen JJ; Rongen-Westerlaken C; Drop SL
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4013-21. PubMed ID: 8923853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of growth hormone supplementation on adult height in turner syndrome: results of the Canadian randomized controlled trial.
    Stephure DK;
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3360-6. PubMed ID: 15784709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gradually increasing ethinyl estradiol for Turner syndrome may produce good final height but not ideal BMD.
    Hasegawa Y; Ariyasu D; Izawa M; Igaki-Miyamoto J; Fukuma M; Hatano M; Yagi H; Goto M
    Endocr J; 2017 Feb; 64(2):221-227. PubMed ID: 27916781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone treatment of early growth failure in toddlers with Turner syndrome: a randomized, controlled, multicenter trial.
    Davenport ML; Crowe BJ; Travers SH; Rubin K; Ross JL; Fechner PY; Gunther DF; Liu C; Geffner ME; Thrailkill K; Huseman C; Zagar AJ; Quigley CA
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3406-16. PubMed ID: 17595258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salutary effects of combining early very low-dose systemic estradiol with growth hormone therapy in girls with Turner syndrome.
    Rosenfield RL; Devine N; Hunold JJ; Mauras N; Moshang T; Root AW
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6424-30. PubMed ID: 16189255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study confirms oxandrolone-associated improvement in height in growth hormone-treated adolescent girls with Turner syndrome.
    Zeger MP; Shah K; Kowal K; Cutler GB; Kushner H; Ross JL
    Horm Res Paediatr; 2011; 75(1):38-46. PubMed ID: 20733274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth-promoting effect of growth hormone and low dose ethinyl estradiol in girls with Turner's syndrome.
    Vanderschueren-Lodeweyckx M; Massa G; Maes M; Craen M; van Vliet G; Heinrichs C; Malvaux P
    J Clin Endocrinol Metab; 1990 Jan; 70(1):122-6. PubMed ID: 2294126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GH treatment to final height produces similar height gains in patients with SHOX deficiency and Turner syndrome: results of a multicenter trial.
    Blum WF; Ross JL; Zimmermann AG; Quigley CA; Child CJ; Kalifa G; Deal C; Drop SL; Rappold G; Cutler GB
    J Clin Endocrinol Metab; 2013 Aug; 98(8):E1383-92. PubMed ID: 23720786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of estrogen therapy on the growth of Turner syndrome in girls treated with growth hormone].
    Morin A; Guimarey L; Apezteguia M; Santucci Z
    Medicina (B Aires); 2001; 61(3):271-4. PubMed ID: 11474872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant growth hormone in children and adolescents with Turner syndrome.
    Cave CB; Bryant J; Milne R
    Cochrane Database Syst Rev; 2003; (3):CD003887. PubMed ID: 12917993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Final height in girls with Turner's syndrome treated with once or twice daily growth hormone injections. Dutch Advisory Group on Growth Hormone.
    Sas TC; de Muinck Keizer-Schrama SM; Stijnen T; van Teunenbroek A; Hokken-Koelega AC; Waelkens JJ; Massa GG; Vulsma T; Gerver WJ; Reeser HM; Delemarre-van de Waal HE; Jansen M; Drop SL
    Arch Dis Child; 1999 Jan; 80(1):36-41. PubMed ID: 10325756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone.
    Nilsson KO; Albertsson-Wikland K; Alm J; Aronson S; Gustafsson J; Hagenäs L; Häger A; Ivarsson SA; Karlberg J; Kriström B; Marcus C; Moell C; Ritzen M; Tuvemo T; Wattsgård C; Westgren U; Westphal O; Aman J
    J Clin Endocrinol Metab; 1996 Feb; 81(2):635-40. PubMed ID: 8636281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.